Mental health apps face a fundamental credibility problem: demonstrating efficacy requires both clinical evidence and proof that users actually stick with the intervention. The second part often matters more than the first.
On the evidence side, apps tend to draw from established modalities. Several providers embed cognitive behavioural therapy, acceptance and commitment therapy, or mindfulness practices [#252][#245]. The strength here is that these therapies have existing clinical literature; apps don't need to invent efficacy from scratch. But that inherited evidence doesn't automatically transfer to the digital version. One guest acknowledged this plainly: whether leading apps like Calm have conducted clinical trials remains unclear [Ep 15].
The harder barrier is engagement. An independent study found average two-week retention among top-performing mental health apps was four percent [#425]. You cannot demonstrate a therapeutic effect if the tool goes unused. This is why some developers now prioritise adaptive, personalised experiences through generative AI, which improves engagement and adherence to treatment protocols [#425]. Others combine CBT with physiological monitoring to address mental health from multiple angles rather than cognitive alone [#252]. The assumption is that better adherence to a validated approach yields measurable outcomes. But the evidence-gathering loop only closes if people continue using the app past the first weeks.
Search 450+ episodes and 42,000 chunks of healthtech conversation.